Fluorine-18 prostate-specific membrane antigen (PSMA)-1007 PET/CT was superior to multiparametric MRI for primary locoregional staging of prostate cancer, according to results from a phase II ...

Fluorine-18 prostate-specific membrane antigen (PSMA)-1007 PET/CT improves locoregional staging compared with MRI in patients undergoing surgery for intermediate and high-risk prostate cancer. PSMA ...

PET scans can light up tumors in the body and help doctors determine if they are cancerous or benign (noncancerous). The results of a PET scan help guide medical decisions. A PET scan is a type of ...

Prostate-specific membrane antigen (PSMA)-PET/CT imaging identified metastatic prostate cancer in almost half of high-risk cases missed by conventional imaging, a retrospective analysis showed.

Expert Rev Anticancer Ther. 2009;9(1):75-96. Based on the available data, FDG-PET alone appears to be of limited use in differentiating tumors of low malignant potential from benign tumors and ovarian ...

An MRI-based imaging technique developed at the University of Cambridge predicts the response of ovarian cancer tumors to treatment, and rapidly reveals how well treatment is working, in ...

Full-body MRIs can find early signs of disease, including cancer, without using radiation. These scans can be expensive and are often not covered by insurance without a medical reason. Full-body MRIs ...

What if I Got a Whole-Body MRI? Fred Hutch and UW Medicine radiologists do not provide reinterpretations of whole-body MRIs. If you’ve had a whole-body MRI screening and have a question or concern ...

Whole-body screening MRI (wb-MRI) for asymptomatic patients has become a relevant topic for U.S. cancer centers. There is a growing number of for-profit centers offering wb-MRI scans for asymptomatic ...